Philip W. Lavori
Academic Appointments
- Professor, Health Research & Policy - Biostatistics
- Member, Stanford Cancer Institute
- Professor (By courtesy), Natural Sciences Cluster - Statistics
Key Documents
Contact Information
- Academic Offices
Personal Information Email Tel (650) 725-6109
Professional Overview
Administrative Appointments
- Chair, Dept. of Health Research and Policy (2005 - present)
- Co-Director, Spectrum (home of NIH Clinical and Translational Science Award) (2008 - present)
- Director Biostatistics, Epidemiology and Study Design Program, Spectrum (2008 - present)
- Director, Biostatistics Shared Resource, Stanford Comprehensive Cancer Center (2004 - present)
- Acting Director, Veterans Affairs Cooperative Studies Program (National HQ) (2002 - 2004)
- Director, Veterans Affairs Cooperative Studies Program Coordinating Center, Palo Alto (1992 - 2005)
Honors and Awards
- Harvard Award in Psychiatric Epidemiology and Biostatistics, Harvard School of Public Health (2011)
- Leadership Award, Department of Veterans Affairs Research and Development Office (2002-2004)
Professional Education
| PhD: | Cornell University, Mathematics (1974) |
| MA: | Cornell University, Mathematics (1972) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Biostatistics, clinical trials, longitudinal studies, casual inference from observational studies, genetic tissue banking, informed consent. Trial designs for dynamic (adaptive) treatment regimes, psychiatric research, cancer.
Publications
- Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern Med. 2013; (2): 113-21
- Adaptive trial designs. Annu Rev Pharmacol Toxicol. 2012: 101-10
- Clinical trial designs for testing biomarker-based personalized therapies. Clin Trials. 2012; (2): 141-54
- Efficient design and inference for multistage randomized trials of individualized treatment policies. Biostatistics. 2012; (1): 142-52
- Influence of body mass index on effects of a shared asthma treatment decision-making intervention. Am J Respir Crit Care Med. 2012; (5): 591-3
- Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer. Clin Lung Cancer. 2012; (1): 52-8
Help